why choose us

First received: May 02, 2023

Clinical Trial: CP101 for the Treatment of Ulcerative Colitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ulcerative Colitis

Study Type: INTERVENTIONAL


Official Title: CP101 for the Treatment of Ulcerative Colitis

Brief Summary: This is a dose ranging exploratory phase 1 pilot study to assess engraftment, safety, and efficacy of CP101, an oral microbiome therapeutic, in participants with active mild-to-moderate Ulcerative colitis.A total of 30 patients who meet eligibility criteria will be randomized 1:1 to either a short or extended induction dosing with CP101.An assessment of the microbiome will occur at baseline, Day 6, Week 4, Week 8, Week 12, Week 16, and Week 24.

Read more